Log in to save to my catalogue

The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising...

The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5124125

The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine

About this item

Full title

The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine

Publisher

Cambridge, UK: Cambridge University Press

Journal title

British journal of nutrition, 2016-10, Vol.116 (7), p.1175-1187

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

Necrotising enterocolitis (NEC) is a common disease in premature infants characterised by intestinal ischaemia and necrosis. The only effective preventative strategy against NEC is the administration of breast milk, although the protective mechanisms remain unknown. We hypothesise that an abundant human milk oligosaccharide (HMO) in breast milk, 2′...

Alternative Titles

Full title

The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5124125

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5124125

Other Identifiers

ISSN

0007-1145

E-ISSN

1475-2662

DOI

10.1017/S0007114516002944

How to access this item